Analyst Rating Flashback: Impax Laboratories Up 1.9% Since Upgraded 7 Days Ago (IPXL)
June 29, 2016 at 01:14 AM EDT
One week ago Impax Laboratories (NASDAQ:IPXL) was upgraded from Underperform to Neutral at BofA/Merrill. Impax Laboratories shares are selling at $28.84, 1.9% above the $28.31 price point of one...
